Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

Status Recruiting

Clinical Trial Summary

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00349505
Study type	Interventional
Source	Gustave Roussy, Cancer Campus, Grand Paris
Contact	Dominique ELIAS, MD, PhD
Phone	00 33 014-211-5441
Email	elias@igr.fr
Status	Recruiting
Phase	Phase 2
Start date	September 2004

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05059444` - ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting	`NCT05470920` - Genetic Testing Decision Aid	N/A
Recruiting	`NCT02611024` - Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors	Phase 1/Phase 2
Withdrawn	`NCT01138137` - N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer	Phase 1
Recruiting	`NCT02437812` - Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma	Phase 2
Terminated	`NCT02107378` - Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma	Phase 2
Recruiting	`NCT02344095` - A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer	Phase 1
Recruiting	`NCT05086692` - A Beta-only IL-2 ImmunoTherapY Study	Phase 1/Phase 2
Recruiting	`NCT04834544` - A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care	Phase 2